Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
NCT05625633

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Led by Western Institute for Veterans Research · Updated on 2024-04-05

120

Participants Needed

2

Research Sites

140 weeks

Total Duration

On this page

Sponsors

W

Western Institute for Veterans Research

Lead Sponsor

U

University of Utah

Collaborating Sponsor

AI-Summary

What this Trial Is About

This double-blinded clinical trial randomly assigns participants with refractory cutaneous warts to receive either treatment with the human papillomavirus (HPV) vaccine or a placebo to assess the efficacy of HPV vaccination for the treatment of refractory cutaneous warts.

CONDITIONS

Official Title

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be able to understand and provide written informed consent
  • Age 18 or older
  • Clinical diagnosis of cutaneous warts
  • Must have received prior treatment for cutaneous warts such as curettage, cryotherapy, salicylic acid, or intralesional Candida antigen injection
Not Eligible

You will not qualify if you...

  • Untreated cutaneous warts
  • Presence of anogenital warts
  • Presence of oral warts
  • Received treatment for cutaneous warts in the past 4 weeks
  • Active acute illness
  • Immunosuppression
  • Known hypersensitivity to HPV vaccination
  • Receiving any other investigational treatment
  • Pregnancy or planned pregnancy during the study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Utah Midvalley Health Center

Salt Lake City, Utah, United States, 84107

Actively Recruiting

2

VA Salt Lake City Health Care System

Salt Lake City, Utah, United States, 84148

Actively Recruiting

Loading map...

Research Team

L

Lowell Nicholson, MD

CONTACT

J

Jamie Rhoads, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts | DecenTrialz